🔎 Trials Near Me

Home › Neoplasie mieloproliferative › California

Studi clinici su Neoplasie mieloproliferative nello stato di California

17 studi su Neoplasie mieloproliferative cercano partecipanti presso sedi nello stato di California.

Città nello stato di California

Testo ufficiale dello studio (inglese)

A Phase 1 Study of PRT12396 in Participants With Select Myeloproliferative Neoplasms

  • UCLA Ronald Reagan Medical Center, Los Angeles
In reclutamentoFase 1
Età 18 e oltre · Tutti i sessi · Aggiornato il 1 ott 2026 · NCT07469891

A Randomized Study of ASTX727 With or Without Iadademstat in Advanced Myeloproliferative Neoplasms (MPNs)

  • UCI Health - Chao Family Comprehensive Cancer Center and Ambulatory Care, Irvine
  • UC Irvine Health/Chao Family Comprehensive Cancer Center, Orange
  • Stanford Cancer Institute Palo Alto, Palo Alto
  • e altri 1
In reclutamentoFase 2
Età 18 e oltre · Tutti i sessi · Aggiornato il 30 set 2026 · NCT06661915

MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)

  • Kaiser Permanente Dublin, Dublin
  • Kaiser Permanente-Fremont, Fremont
  • Kaiser Permanente Fresno Orchard Plaza, Fresno
  • e altri 21
In reclutamentoFase 2
Età 18 e oltre · Tutti i sessi · Aggiornato il 25 set 2026 · NCT05564390

Study of DISC-0974 (RALLY-MF) in Participants With Myelofibrosis or Myelodysplastic Syndrome and Anemia

  • City of Hope - Duarte, Duarte
  • City of Hope - Lennar, Irvine
  • UCLA, Los Angeles
  • e altri 1
In reclutamentoFase 1/2
Età 18 e oltre · Tutti i sessi · Aggiornato il 23 set 2026 · NCT05320198

Testing New Therapies for Patients With Acute Myeloid Leukemia Who Are Newly Diagnosed and Have Not Yet Started Treatment (A MyeloMATCH Treatment Trial)

  • Cedars-Sinai Medical Center, Los Angeles
  • Kaiser Permanente-Oakland, Oakland
  • Kaiser Permanente-Roseville, Roseville
  • e altri 3
In reclutamentoFase 2
Età da 18 a 59 · Tutti i sessi · Aggiornato il 22 set 2026 · NCT05554406

(Apex) Bezuclastinib in Patients With Advanced Systemic Mastocytosis

  • City of Hope Comprehensive Cancer Center, Duarte
  • UCLA Medical Center, Los Angeles
  • Stanford Cancer Institute, Stanford
In reclutamentoFase 2
Età 18 e oltre · Tutti i sessi · Aggiornato il 15 set 2026 · NCT04996875

Project: Every Child for Younger Patients With Cancer

  • Kaiser Permanente Downey Medical Center, Downey
  • City of Hope Comprehensive Cancer Center, Duarte
  • Loma Linda University Medical Center, Loma Linda
  • e altri 15
In reclutamentoStudio osservazionale
Fino a 25 anni · Tutti i sessi · Aggiornato il 25 ago 2026 · NCT02402244

A Study to Evaluate INCA035784 in Participants With Myeloproliferative Neoplasms

  • Stanford University, Palo Alto
In reclutamentoFase 1
Età 18 e oltre · Tutti i sessi · Aggiornato il 6 ago 2026 · NCT07008118

A Vaccine (CMV-MVA Triplex Vaccine) for the Enhancement of CMV-Specific Immunity and the Prevention of CMV Viremia in Patients Undergoing Haploidentical Hematopoietic Stem Cell Transplant

  • City of Hope Medical Center, Duarte
In reclutamentoFase 1Volontari sani benvenuti
Età da 18 a 75 · Tutti i sessi · Aggiornato il 28 lug 2026 · NCT07020533

Study of INCA036978 in Participants With Myeloproliferative Neoplasms

  • City of Hope-Lennar Foundation Cancer Center, Irvine
  • Usc Norris Comprehensive Cancer Center, Los Angeles
  • UCLA Medical Hematology & Oncology, Los Angeles
In reclutamentoFase 1
Età 18 e oltre · Tutti i sessi · Aggiornato il 22 lug 2026 · NCT07441694

Vedolizumab Plus Post-transplant Cyclophosphamide and Short Course Tacrolimus for the Prevention of Graft Versus Host Disease in Patients Undergoing Allogeneic Hematopoietic Cell Transplantation After Reduced Intensity Conditioning

  • City of Hope Medical Center, Duarte
In reclutamentoFase 2
Età da 18 a 80 · Tutti i sessi · Aggiornato il 29 giu 2026 · NCT06815003

A Study to Evaluate INCA033989 Administered as a Monotherapy or in Combination With Ruxolitinib in Participants With Myeloproliferative Neoplasms

  • City of Hope Medical Center, Duarte
  • Stanford Cancer Institute, Palo Alto
In reclutamentoFase 1
Età 18 e oltre · Tutti i sessi · Aggiornato il 17 apr 2026 · NCT06034002

A Platform Protocol to Investigate Post-Transplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis in Patients With Hematologic Malignancies Undergoing Mismatched Unrelated Donor Peripheral Blood Stem Cell Transplantation

  • City of Hope, Duarte
  • Stanford, Palo Alto
In reclutamentoFase 2
Età da 18 a 66 · Tutti i sessi · Aggiornato il 17 mar 2026 · NCT06859424

CMV-MVA Triplex Vaccination in HLA-Matched Related Stem Cell Donors for the Prevention of CMV Infection in Patients Undergoing Hematopoietic Stem Cell Transplant

  • City of Hope Medical Center, Duarte
In reclutamentoFase 2Volontari sani benvenuti
Età da 18 a 75 · Tutti i sessi · Aggiornato il 10 mar 2026 · NCT06059391

An Optimal Dose Finding Study of N-Acetylcysteine in Patients With Myeloproliferative Neoplasms

  • University of California, Irvine, Irvine
In reclutamentoFase 1/2
Età 18 e oltre · Tutti i sessi · Aggiornato il 10 mar 2026 · NCT05123365

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

  • Massive Bio SYNERGY-AI site, Duarte
  • Massive Bio SYNERGY-AI site, Irvine
  • Massive Bio SYNERGY-AI site, La Jolla
  • e altri 3
In reclutamentoStudio osservazionale
Tutte le età · Tutti i sessi · Aggiornato il 28 ott 2025 · NCT03452774

Leading in MPNs Beyond Ruxolitinib in Combo With T-Regs

  • UC Davis Health, Sacramento
In reclutamentoFase 1
Età 18 e oltre · Tutti i sessi · Aggiornato il 13 apr 2025 · NCT05423691

Fonte: ClinicalTrials.gov, dati recuperati il 5 ott 2026. Ogni studio stabilisce i propri criteri di idoneità; è il team di ricerca a decidere chi può partecipare.